secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001493152-24-000338
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience extends merger deadline, secures $5M financing from NAYA, extends convertible notes
--------------------------------------------------------------------------------

- Second Amendment extends merger end date to April 30, 2024; interim PIPE reduced to $2M of preferred stock at $5/share with schedule.
- NAYA agrees to purchase up to 1M Series A Preferred shares at $5/share for $5M total, with tranches starting Dec 2023.
- Convertible notes ($410k) maturity extended to June 30, 2024; conversion and warrant exercise prices reduced to $2.25.
- CEO and CFO salary temporarily reduced to $105k from Aug 2023; reverted to $260k and $215k on Jan 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224000338/0001493152-24-000338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224000338/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-000338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer